| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 3.71e-08 | 14 | 51 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 3.22e-07 | 23 | 51 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 8.55e-07 | 29 | 51 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 8.55e-07 | 29 | 51 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.65e-06 | 34 | 51 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | glycolipid binding | 7.35e-06 | 49 | 51 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 3.06e-05 | 70 | 51 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.61e-05 | 73 | 51 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 3.85e-05 | 149 | 51 | 5 | GO:1990782 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 8.20e-05 | 90 | 51 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.41e-04 | 196 | 51 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.94e-04 | 210 | 51 | 5 | GO:0019903 | |
| GeneOntologyMolecularFunction | phosphatase binding | 5.56e-04 | 264 | 51 | 5 | GO:0019902 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 9.90e-04 | 173 | 51 | 4 | GO:0070851 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.92e-03 | 207 | 51 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.95e-03 | 208 | 51 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.80e-03 | 230 | 51 | 4 | GO:0005516 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 3.43e-09 | 24 | 52 | 5 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 9.48e-09 | 29 | 52 | 5 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 3.53e-08 | 14 | 52 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 4.80e-08 | 15 | 52 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 4.80e-08 | 15 | 52 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 4.80e-08 | 15 | 52 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 4.80e-08 | 15 | 52 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 6.39e-08 | 16 | 52 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 8.34e-08 | 17 | 52 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 8.34e-08 | 17 | 52 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 8.34e-08 | 17 | 52 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.07e-07 | 18 | 52 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.69e-07 | 20 | 52 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 2.08e-07 | 21 | 52 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 2.08e-07 | 21 | 52 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 2.08e-07 | 21 | 52 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 2.54e-07 | 22 | 52 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.07e-07 | 23 | 52 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.07e-07 | 23 | 52 | 4 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 3.68e-07 | 24 | 52 | 4 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 3.68e-07 | 24 | 52 | 4 | GO:0002420 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.26e-07 | 187 | 52 | 7 | GO:0007156 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 4.37e-07 | 25 | 52 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 4.37e-07 | 25 | 52 | 4 | GO:0002423 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 5.07e-07 | 118 | 52 | 6 | GO:0001570 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 6.04e-07 | 27 | 52 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 7.03e-07 | 28 | 52 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.07e-06 | 31 | 52 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.23e-06 | 32 | 52 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.23e-06 | 32 | 52 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.23e-06 | 32 | 52 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.35e-06 | 76 | 52 | 5 | GO:0042269 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.39e-06 | 33 | 52 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.39e-06 | 33 | 52 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.57e-06 | 34 | 52 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.57e-06 | 34 | 52 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.74e-06 | 80 | 52 | 5 | GO:0002715 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.77e-06 | 35 | 52 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 1.84e-06 | 147 | 52 | 6 | GO:0031341 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.09e-06 | 83 | 52 | 5 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.49e-06 | 38 | 52 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 2.77e-06 | 39 | 52 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | female pregnancy | 2.89e-06 | 249 | 52 | 7 | GO:0007565 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 3.07e-06 | 40 | 52 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 3.39e-06 | 41 | 52 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 3.72e-06 | 166 | 52 | 6 | GO:0002698 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 3.74e-06 | 42 | 52 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 4.30e-06 | 96 | 52 | 5 | GO:0002704 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 4.96e-06 | 45 | 52 | 4 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 5.42e-06 | 46 | 52 | 4 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 5.42e-06 | 46 | 52 | 4 | GO:0072574 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 5.91e-06 | 47 | 52 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 5.91e-06 | 47 | 52 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 5.91e-06 | 47 | 52 | 4 | GO:0034104 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 6.67e-06 | 105 | 52 | 5 | GO:0042267 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 7.00e-06 | 49 | 52 | 4 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 7.00e-06 | 49 | 52 | 4 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 7.59e-06 | 50 | 52 | 4 | GO:0002834 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 7.87e-06 | 290 | 52 | 7 | GO:0044703 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 8.01e-06 | 109 | 52 | 5 | GO:0002228 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 8.60e-06 | 294 | 52 | 7 | GO:0044706 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 8.89e-06 | 52 | 52 | 4 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 9.60e-06 | 53 | 52 | 4 | GO:0034110 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 1.19e-05 | 309 | 52 | 7 | GO:0002703 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.20e-05 | 56 | 52 | 4 | GO:0002418 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.29e-05 | 313 | 52 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.48e-05 | 59 | 52 | 4 | GO:0045671 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.50e-05 | 124 | 52 | 5 | GO:0001910 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 1.54e-05 | 449 | 52 | 8 | GO:0002449 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 1.58e-05 | 60 | 52 | 4 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 1.58e-05 | 60 | 52 | 4 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 1.69e-05 | 61 | 52 | 4 | GO:0060259 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.92e-05 | 63 | 52 | 4 | GO:0007157 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 2.31e-05 | 66 | 52 | 4 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 2.45e-05 | 67 | 52 | 4 | GO:0045601 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 2.51e-05 | 232 | 52 | 6 | GO:0002706 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 2.75e-05 | 69 | 52 | 4 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 2.91e-05 | 70 | 52 | 4 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 2.91e-05 | 70 | 52 | 4 | GO:1900047 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 2.96e-05 | 239 | 52 | 6 | GO:0050777 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 3.08e-05 | 71 | 52 | 4 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 3.08e-05 | 71 | 52 | 4 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 3.19e-05 | 145 | 52 | 5 | GO:0045833 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 3.26e-05 | 72 | 52 | 4 | GO:0032692 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 3.26e-05 | 72 | 52 | 4 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 3.44e-05 | 73 | 52 | 4 | GO:0042304 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 3.48e-05 | 246 | 52 | 6 | GO:0045216 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 3.88e-05 | 151 | 52 | 5 | GO:1902106 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 4.81e-05 | 158 | 52 | 5 | GO:0045446 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 4.93e-05 | 80 | 52 | 4 | GO:0046850 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 4.96e-05 | 159 | 52 | 5 | GO:1903707 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 6.25e-05 | 85 | 52 | 4 | GO:1903670 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 6.25e-05 | 85 | 52 | 4 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 6.55e-05 | 86 | 52 | 4 | GO:0042058 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 6.85e-05 | 87 | 52 | 4 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 7.00e-05 | 171 | 52 | 5 | GO:0050868 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 8.16e-05 | 91 | 52 | 4 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 8.16e-05 | 91 | 52 | 4 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 8.88e-05 | 93 | 52 | 4 | GO:1900046 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 8.88e-05 | 93 | 52 | 4 | GO:1901184 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 6.06e-08 | 16 | 52 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | side of membrane | TRAF3IP2 THADA PSG2 PSG5 PSG6 SIGLEC8 PSG11 CNTN5 KDR CR1L IL4R MUSK | 1.18e-06 | 875 | 52 | 12 | GO:0098552 |
| GeneOntologyCellularComponent | external side of plasma membrane | 4.76e-06 | 519 | 52 | 9 | GO:0009897 | |
| GeneOntologyCellularComponent | adherens junction | 1.40e-05 | 212 | 52 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 7.43e-05 | 90 | 52 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | receptor complex | 8.69e-05 | 581 | 52 | 8 | GO:0043235 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.03e-04 | 98 | 52 | 4 | GO:0060170 | |
| GeneOntologyCellularComponent | cell surface | 3.55e-04 | 1111 | 52 | 10 | GO:0009986 | |
| GeneOntologyCellularComponent | cell-cell junction | 6.18e-04 | 591 | 52 | 7 | GO:0005911 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 6.26e-04 | 157 | 52 | 4 | GO:1902554 | |
| GeneOntologyCellularComponent | T cell receptor complex | 7.21e-04 | 163 | 52 | 4 | GO:0042101 | |
| GeneOntologyCellularComponent | protein kinase complex | 8.43e-04 | 170 | 52 | 4 | GO:1902911 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.17e-03 | 320 | 52 | 5 | GO:0016323 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.44e-03 | 335 | 52 | 5 | GO:0061695 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.83e-03 | 354 | 52 | 5 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 2.44e-03 | 378 | 52 | 5 | GO:0045178 | |
| GeneOntologyCellularComponent | anchoring junction | 2.66e-03 | 976 | 52 | 8 | GO:0070161 | |
| GeneOntologyCellularComponent | cell projection membrane | 4.27e-03 | 431 | 52 | 5 | GO:0031253 | |
| GeneOntologyCellularComponent | cilium | 6.54e-03 | 898 | 52 | 7 | GO:0005929 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.97e-07 | 17 | 44 | 4 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 4.91e-07 | 21 | 44 | 4 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 8.66e-07 | 24 | 44 | 4 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 1.42e-06 | 27 | 44 | 4 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 1.65e-06 | 28 | 44 | 4 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 2.52e-06 | 31 | 44 | 4 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 2.52e-06 | 31 | 44 | 4 | MP:0008964 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 4.16e-06 | 35 | 44 | 4 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 4.67e-06 | 36 | 44 | 4 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 6.48e-06 | 39 | 44 | 4 | MP:0030022 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 1.06e-05 | 44 | 44 | 4 | MP:0031023 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.38e-05 | 47 | 44 | 4 | MP:0031617 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.63e-05 | 49 | 44 | 4 | MP:0020948 | |
| MousePheno | decreased cellular glucose uptake | 2.23e-05 | 53 | 44 | 4 | MP:0003926 | |
| MousePheno | decreased respiratory quotient | 2.34e-05 | 110 | 44 | 5 | MP:0010379 | |
| MousePheno | abnormal fatty acid oxidation | 2.41e-05 | 54 | 44 | 4 | MP:0010953 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 3.66e-05 | 60 | 44 | 4 | MP:0009790 | |
| MousePheno | abnormal lipid oxidation | 3.91e-05 | 61 | 44 | 4 | MP:0010951 | |
| MousePheno | increased insulin secretion | 4.73e-05 | 64 | 44 | 4 | MP:0003058 | |
| MousePheno | abnormal muscle cell glucose uptake | 5.66e-05 | 67 | 44 | 4 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 5.66e-05 | 67 | 44 | 4 | MP:0008962 | |
| MousePheno | abnormal vascular wound healing | 7.93e-05 | 73 | 44 | 4 | MP:0004883 | |
| MousePheno | enlarged submandibular lymph nodes | 9.62e-05 | 5 | 44 | 2 | MP:0002742 | |
| MousePheno | abnormal submandibular lymph node morphology | 9.62e-05 | 5 | 44 | 2 | MP:0009627 | |
| MousePheno | decreased oxygen consumption | 1.08e-04 | 79 | 44 | 4 | MP:0005290 | |
| MousePheno | polyphagia | 1.13e-04 | 80 | 44 | 4 | MP:0001433 | |
| MousePheno | decreased susceptibility to Riboviria infection | 1.25e-04 | 82 | 44 | 4 | MP:0020914 | |
| MousePheno | abnormal insulin secretion | 1.91e-04 | 171 | 44 | 5 | MP:0003564 | |
| MousePheno | abnormal endocrine pancreas secretion | 2.18e-04 | 176 | 44 | 5 | MP:0014195 | |
| MousePheno | abnormal respiratory quotient | 2.30e-04 | 178 | 44 | 5 | MP:0004129 | |
| MousePheno | increased circulating insulin level | 2.41e-04 | 283 | 44 | 6 | MP:0002079 | |
| MousePheno | abnormal pancreas secretion | 2.61e-04 | 183 | 44 | 5 | MP:0002694 | |
| MousePheno | abnormal pancreas physiology | 2.86e-04 | 292 | 44 | 6 | MP:0002693 | |
| MousePheno | abnormal cellular glucose uptake | 2.90e-04 | 102 | 44 | 4 | MP:0003925 | |
| MousePheno | abnormal pancreatic beta cell physiology | 3.59e-04 | 196 | 44 | 5 | MP:0003562 | |
| MousePheno | increased circulating hormone level | 3.86e-04 | 578 | 44 | 8 | MP:0014456 | |
| MousePheno | abnormal endocrine pancreas physiology | 4.12e-04 | 202 | 44 | 5 | MP:0010147 | |
| MousePheno | obese | 4.28e-04 | 113 | 44 | 4 | MP:0001261 | |
| MousePheno | decreased energy expenditure | 5.21e-04 | 119 | 44 | 4 | MP:0004890 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 5.38e-04 | 120 | 44 | 4 | MP:0009786 | |
| MousePheno | increased circulating leptin level | 6.27e-04 | 125 | 44 | 4 | MP:0005669 | |
| MousePheno | decreased susceptibility to viral infection | 6.27e-04 | 125 | 44 | 4 | MP:0002410 | |
| MousePheno | increased hormone level | 7.67e-04 | 641 | 44 | 8 | MP:0014454 | |
| MousePheno | dry eyes | 8.60e-04 | 14 | 44 | 2 | MP:0001337 | |
| MousePheno | increased incidence of tumors by chemical induction | 9.85e-04 | 141 | 44 | 4 | MP:0004499 | |
| MousePheno | abnormal glycogen homeostasis | 1.06e-03 | 144 | 44 | 4 | MP:0005438 | |
| MousePheno | decreased susceptibility to infection | 1.18e-03 | 255 | 44 | 5 | MP:0002409 | |
| MousePheno | abnormal gland physiology | 1.25e-03 | 691 | 44 | 8 | MP:0002164 | |
| MousePheno | abnormal colon morphology | 1.30e-03 | 152 | 44 | 4 | MP:0000495 | |
| MousePheno | decreased circulating triglyceride level | 1.65e-03 | 275 | 44 | 5 | MP:0002644 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 1.96e-03 | 286 | 44 | 5 | MP:0008873 | |
| MousePheno | increased total body fat amount | 2.00e-03 | 424 | 44 | 6 | MP:0010024 | |
| MousePheno | abnormal lean body mass | 2.08e-03 | 749 | 44 | 8 | MP:0003959 | |
| MousePheno | increased incidence of induced tumors | 2.09e-03 | 173 | 44 | 4 | MP:0002021 | |
| Domain | IGc2 | 3.80e-11 | 235 | 52 | 11 | SM00408 | |
| Domain | Ig_sub2 | 3.80e-11 | 235 | 52 | 11 | IPR003598 | |
| Domain | IG | HMCN1 PSG2 PSG5 PSG6 PSG7 SIGLEC8 PSG11 SPEG CNTN5 KDR MUSK NCR3 | 1.35e-09 | 421 | 52 | 12 | SM00409 |
| Domain | Ig_sub | HMCN1 PSG2 PSG5 PSG6 PSG7 SIGLEC8 PSG11 SPEG CNTN5 KDR MUSK NCR3 | 1.35e-09 | 421 | 52 | 12 | IPR003599 |
| Domain | - | AREL1 HMCN1 PSG2 PSG5 PSG6 PSG7 SIGLEC8 PSG11 SPEG CNTN5 KDR IL4R MUSK NCR3 | 2.24e-09 | 663 | 52 | 14 | 2.60.40.10 |
| Domain | ig | 2.44e-09 | 190 | 52 | 9 | PF00047 | |
| Domain | Immunoglobulin | 2.44e-09 | 190 | 52 | 9 | IPR013151 | |
| Domain | Ig_V-set | 3.66e-09 | 199 | 52 | 9 | IPR013106 | |
| Domain | Ig-like_fold | AREL1 HMCN1 PSG2 PSG5 PSG6 PSG7 SIGLEC8 PSG11 SPEG CNTN5 KDR IL4R MUSK NCR3 | 4.99e-09 | 706 | 52 | 14 | IPR013783 |
| Domain | IG_LIKE | HMCN1 PSG2 PSG5 PSG6 PSG7 SIGLEC8 PSG11 SPEG CNTN5 KDR MUSK NCR3 | 7.57e-09 | 491 | 52 | 12 | PS50835 |
| Domain | Ig-like_dom | HMCN1 PSG2 PSG5 PSG6 PSG7 SIGLEC8 PSG11 SPEG CNTN5 KDR MUSK NCR3 | 9.90e-09 | 503 | 52 | 12 | IPR007110 |
| Domain | V-set | 3.96e-08 | 184 | 52 | 8 | PF07686 | |
| Domain | Ig_2 | 5.11e-08 | 73 | 52 | 6 | PF13895 | |
| Domain | Ig_I-set | 9.17e-07 | 190 | 52 | 7 | IPR013098 | |
| Domain | I-set | 9.17e-07 | 190 | 52 | 7 | PF07679 | |
| Domain | - | 2.37e-03 | 26 | 52 | 2 | 3.60.10.10 | |
| Domain | Exo_endo_phos | 2.37e-03 | 26 | 52 | 2 | PF03372 | |
| Domain | Endo/exonuclease/phosphatase | 2.55e-03 | 27 | 52 | 2 | IPR005135 | |
| Domain | Sushi | 9.22e-03 | 52 | 52 | 2 | PF00084 | |
| Domain | CCP | 9.92e-03 | 54 | 52 | 2 | SM00032 | |
| Domain | SUSHI | 1.06e-02 | 56 | 52 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.10e-02 | 57 | 52 | 2 | IPR000436 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 4.89e-06 | 99 | 36 | 5 | MM14624 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.25e-04 | 194 | 36 | 5 | M16312 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.68e-04 | 258 | 36 | 5 | MM14572 | |
| Pubmed | 3.42e-13 | 8 | 52 | 5 | 1690992 | ||
| Pubmed | 1.18e-10 | 162 | 52 | 8 | 25826454 | ||
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 1.55e-10 | 7 | 52 | 4 | 7794280 | |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 3.14e-09 | 13 | 52 | 4 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 3.14e-09 | 13 | 52 | 4 | 1985902 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 10964771 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 3.14e-09 | 13 | 52 | 4 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 3.14e-09 | 13 | 52 | 4 | 16638824 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 20044046 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 32150576 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 22469976 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 3.14e-09 | 13 | 52 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 3.14e-09 | 13 | 52 | 4 | 28035001 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 3.14e-09 | 13 | 52 | 4 | 12832451 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 3.14e-09 | 13 | 52 | 4 | 15316023 | |
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 3.14e-09 | 13 | 52 | 4 | 21670291 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 22162753 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 3.14e-09 | 13 | 52 | 4 | 23935487 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 2702644 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 8380065 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 1279194 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 15331748 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 3.14e-09 | 13 | 52 | 4 | 22406619 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 7628460 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 25724769 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 26374765 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 3.14e-09 | 13 | 52 | 4 | 25972571 | |
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 3.14e-09 | 13 | 52 | 4 | 22092845 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 11801635 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 28913658 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 19008452 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 3.14e-09 | 13 | 52 | 4 | 15220458 | |
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 3.14e-09 | 13 | 52 | 4 | 8500759 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 3.14e-09 | 13 | 52 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 3.14e-09 | 13 | 52 | 4 | 23800882 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 15207636 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 19285068 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 21760897 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 3.14e-09 | 13 | 52 | 4 | 1326665 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 21081647 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 3.14e-09 | 13 | 52 | 4 | 39168268 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 11483763 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 8402684 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 2164599 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 16619040 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 3.14e-09 | 13 | 52 | 4 | 8209741 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 3.14e-09 | 13 | 52 | 4 | 21949477 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 29396368 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 26219866 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 18003729 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 26284027 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 2133556 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 32521208 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 3.14e-09 | 13 | 52 | 4 | 33352461 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 19406938 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 38381498 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 20739537 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 3.14e-09 | 13 | 52 | 4 | 29967450 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 1633107 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 3.14e-09 | 13 | 52 | 4 | 19358828 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 3.14e-09 | 13 | 52 | 4 | 27695943 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 20404914 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 16680193 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 26911181 | ||
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 1653760 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 3.14e-09 | 13 | 52 | 4 | 32027621 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 3.14e-09 | 13 | 52 | 4 | 27777319 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 18848945 | ||
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 37531413 | ||
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 23780386 | ||
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 28567513 | ||
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 8207827 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 4.40e-09 | 14 | 52 | 4 | 34666041 | |
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 19700760 | ||
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 34619794 | ||
| Pubmed | Expression patterns of CD66a and CD117 in the mouse submandibular gland. | 4.40e-09 | 14 | 52 | 4 | 25498293 | |
| Pubmed | Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling. | 4.40e-09 | 14 | 52 | 4 | 29746166 | |
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 9212243 | ||
| Pubmed | CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo. | 4.40e-09 | 14 | 52 | 4 | 27572314 | |
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 1648219 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 4.40e-09 | 14 | 52 | 4 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 4.40e-09 | 14 | 52 | 4 | 32209360 | |
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 11994468 | ||
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 11850617 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 4.40e-09 | 14 | 52 | 4 | 27161904 | |
| Pubmed | 4.40e-09 | 14 | 52 | 4 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 4.40e-09 | 14 | 52 | 4 | 26196244 | |
| Cytoband | 19q13.2 | 3.72e-05 | 164 | 52 | 4 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 5.51e-05 | 1192 | 52 | 8 | chr19q13 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.43e-11 | 11 | 38 | 5 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 4.24e-08 | 163 | 38 | 7 | 590 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.08e-05 | 161 | 38 | 5 | 593 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.19e-03 | 40 | 38 | 2 | 321 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.38e-03 | 57 | 38 | 2 | 1179 | |
| GeneFamily | Immunoglobulin like domain containing | 7.68e-03 | 193 | 38 | 3 | 594 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 2.04e-07 | 128 | 52 | 6 | MM1000 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 2.93e-07 | 224 | 52 | 7 | M40145 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 4.75e-07 | 32 | 52 | 4 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 6.89e-07 | 35 | 52 | 4 | MM757 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 1.15e-06 | 93 | 52 | 5 | M40279 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 2.51e-06 | 48 | 52 | 4 | MM531 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 1.51e-05 | 75 | 52 | 4 | MM605 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN | 1.74e-05 | 162 | 52 | 5 | M8995 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 2.06e-05 | 284 | 52 | 6 | MM987 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 2.71e-05 | 87 | 52 | 4 | MM851 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 3.05e-05 | 182 | 52 | 5 | MM993 | |
| Coexpression | GSE39864_WT_VS_GATA3_KO_TREG_UP | 4.78e-05 | 200 | 52 | 5 | M9064 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 4.89e-05 | 201 | 52 | 5 | MM1006 | |
| Coexpression | LEIN_CHOROID_PLEXUS_MARKERS | 5.68e-05 | 105 | 52 | 4 | M1719 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 5.98e-05 | 505 | 52 | 7 | M39167 | |
| Coexpression | LEIN_CHOROID_PLEXUS_MARKERS | 6.57e-05 | 109 | 52 | 4 | MM1214 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 1.50e-04 | 135 | 52 | 4 | MM965 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 1.74e-04 | 418 | 52 | 6 | M12676 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 1.88e-04 | 143 | 52 | 4 | MM989 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 2.15e-04 | 435 | 52 | 6 | MM1221 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 2.18e-04 | 436 | 52 | 6 | MM1326 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 2.81e-04 | 159 | 52 | 4 | MM760 | |
| Coexpression | DURAND_STROMA_S_UP | 3.18e-04 | 300 | 52 | 5 | M2581 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 3.28e-04 | 302 | 52 | 5 | MM16604 | |
| Coexpression | DURAND_STROMA_S_UP | 3.38e-04 | 304 | 52 | 5 | MM1083 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 4.07e-04 | 490 | 52 | 6 | MM1001 | |
| CoexpressionAtlas | placenta | 7.25e-09 | 349 | 50 | 10 | placenta | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.36e-10 | 136 | 52 | 7 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-07 | 196 | 52 | 6 | 4740ef6e428f1ccc81fc98c3b868afd38ce60535 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-06 | 159 | 52 | 5 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.41e-06 | 165 | 52 | 5 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-06 | 175 | 52 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.97e-06 | 192 | 52 | 5 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.62e-06 | 200 | 52 | 5 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.07e-05 | 153 | 52 | 4 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.65e-05 | 160 | 52 | 4 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 161 | 52 | 4 | 176a4a72bb4892932da3c834d1fea5e211847f92 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.52e-05 | 169 | 52 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.41e-05 | 177 | 52 | 4 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-05 | 178 | 52 | 4 | 8b939659f713eea50a1a6e28b571f680ca0b4c12 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.65e-05 | 179 | 52 | 4 | f5bb4d3a27d56698473219970e764084096cc582 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.65e-05 | 179 | 52 | 4 | fa03ec3cc0132f977b4cb28e7b23789732375183 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 180 | 52 | 4 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 180 | 52 | 4 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.90e-05 | 181 | 52 | 4 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.90e-05 | 181 | 52 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-05 | 182 | 52 | 4 | be9c312a44868d4ee266a64d066feb8c5bce5687 | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-05 | 182 | 52 | 4 | 74dbb706bcaa0f8c922bf3b0424bce5bb27167fa | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.03e-05 | 182 | 52 | 4 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.16e-05 | 183 | 52 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-05 | 183 | 52 | 4 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.42e-05 | 185 | 52 | 4 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.56e-05 | 186 | 52 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.69e-05 | 187 | 52 | 4 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.69e-05 | 187 | 52 | 4 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.69e-05 | 187 | 52 | 4 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 188 | 52 | 4 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 188 | 52 | 4 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.83e-05 | 188 | 52 | 4 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.83e-05 | 188 | 52 | 4 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.83e-05 | 188 | 52 | 4 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.98e-05 | 189 | 52 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.12e-05 | 190 | 52 | 4 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.12e-05 | 190 | 52 | 4 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 7.27e-05 | 191 | 52 | 4 | b5328733da3d3d77c4f6fc5e2ba2035f8898f172 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-05 | 191 | 52 | 4 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-05 | 191 | 52 | 4 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.41e-05 | 192 | 52 | 4 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-05 | 192 | 52 | 4 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.41e-05 | 192 | 52 | 4 | 93903576dddd8227328e4ced75aa7625eedb9baf | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 7.41e-05 | 192 | 52 | 4 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.41e-05 | 192 | 52 | 4 | 87c7780cf72f4c204f2a5f6655309d47a23c08ae | |
| ToppCell | P15-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.41e-05 | 192 | 52 | 4 | a476895b7b252c388d6346eacbc72f0115b1443e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.56e-05 | 193 | 52 | 4 | cfab88935abe0a15632c5eec8ff00a857ec9b3ed | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.56e-05 | 193 | 52 | 4 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 7.56e-05 | 193 | 52 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.72e-05 | 194 | 52 | 4 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.72e-05 | 194 | 52 | 4 | aaecde88bd54134a938e76cdf059c1c2653e4e77 | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 7.87e-05 | 195 | 52 | 4 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-05 | 195 | 52 | 4 | 7155cc12cc6a97efd626bbdb95249fb3d7041dcf | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-05 | 195 | 52 | 4 | a52ee3ad6cd317f10b9308450517861ef2e363bb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-05 | 195 | 52 | 4 | b3660779f274ca97dd844cf83f62d85ba88cb182 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.87e-05 | 195 | 52 | 4 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass | 7.87e-05 | 195 | 52 | 4 | ea9ff25020c2fcd1bab80e1829af0f4e4777de8b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.19e-05 | 197 | 52 | 4 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.19e-05 | 197 | 52 | 4 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-05 | 199 | 52 | 4 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.51e-05 | 199 | 52 | 4 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-05 | 199 | 52 | 4 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-05 | 199 | 52 | 4 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.51e-05 | 199 | 52 | 4 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.68e-05 | 200 | 52 | 4 | 0aa316b71f195ecf17ee897e307f8928a755a637 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.68e-05 | 200 | 52 | 4 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.68e-05 | 200 | 52 | 4 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.68e-05 | 200 | 52 | 4 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 103 | 52 | 3 | 3f4e4600c8a9af3534479ca19905c3d31c4c55bb | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb-Excitatory_Neuron.Sc17a7.Rorb-Gpr83_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.73e-04 | 108 | 52 | 3 | 5af010a1ee6535b144ccd16999c225508a4b3433 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-04 | 123 | 52 | 3 | 87401764a073c1808f214642a9c84299c78f7ec7 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.83e-04 | 140 | 52 | 3 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-04 | 147 | 52 | 3 | 64fa0753a3a79f492ef8acc6942bf90d379a983f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 7.12e-04 | 150 | 52 | 3 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.12e-04 | 150 | 52 | 3 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.12e-04 | 150 | 52 | 3 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.26e-04 | 151 | 52 | 3 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.40e-04 | 152 | 52 | 3 | 33afa18b09f8c7b058b5eac5b5873cc466eeb4b9 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.54e-04 | 153 | 52 | 3 | a44da11a913b19edde6c5d1d6e625c24b20ecbfd | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.69e-04 | 154 | 52 | 3 | 6c1e7682c43c40b58b371c58deb10b839700ebcc | |
| ToppCell | facs-GAT-Fat-24m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 157 | 52 | 3 | c4a0b6c95d353691fd2846002ce4bc7c2b0edd1c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-04 | 159 | 52 | 3 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.74e-04 | 161 | 52 | 3 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.74e-04 | 161 | 52 | 3 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.74e-04 | 161 | 52 | 3 | 22fea192cd5f6d3544533d8b10e1d74dfedf0f05 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tregs|Liver / Manually curated celltypes from each tissue | 8.74e-04 | 161 | 52 | 3 | e0fd0c5f72d6a2900827e7bc2608ce3b8df5686b | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.74e-04 | 161 | 52 | 3 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tregs|GI_large-bowel / Manually curated celltypes from each tissue | 8.90e-04 | 162 | 52 | 3 | 9a5e65c45f73a6a685b8362aa2e6aea77181caa3 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.90e-04 | 162 | 52 | 3 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.06e-04 | 163 | 52 | 3 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.06e-04 | 163 | 52 | 3 | f21951e63188eb0c04675a8f81a0da495c26c007 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.22e-04 | 164 | 52 | 3 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-MAIT|ICU-SEP / Disease, Lineage and Cell Type | 9.22e-04 | 164 | 52 | 3 | db863a44fc0dad5518c47fdbf64ea21d6f36f089 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_cell|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 9.22e-04 | 164 | 52 | 3 | e4d43af7eb04d55328791b554bdf3a7ce6818027 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.38e-04 | 165 | 52 | 3 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.38e-04 | 165 | 52 | 3 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.38e-04 | 165 | 52 | 3 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| Computational | Neighborhood of EGFR | 2.71e-08 | 32 | 31 | 5 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 4.35e-08 | 35 | 31 | 5 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 1.12e-07 | 42 | 31 | 5 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.79e-07 | 46 | 31 | 5 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 2.48e-07 | 49 | 31 | 5 | GNF2_KISS1 | |
| Computational | Neighborhood of CDKN1C | 6.06e-05 | 27 | 31 | 3 | GNF2_CDKN1C | |
| Computational | Genes in the cancer module 85. | 4.12e-04 | 51 | 31 | 3 | MODULE_85 | |
| Computational | Genes in the cancer module 199. | 5.72e-04 | 57 | 31 | 3 | MODULE_199 | |
| Drug | AC1L1IPV | 4.60e-08 | 43 | 52 | 5 | CID000004683 | |
| Drug | PF-00539745-00 [351321-33-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 5.52e-06 | 196 | 52 | 6 | 5974_DN | |
| Drug | 1-TRIM | 8.95e-06 | 18 | 52 | 3 | CID000001359 | |
| Drug | NSC-4928 | 9.37e-06 | 58 | 52 | 4 | CID000221086 | |
| Drug | Rgd Peptide | 1.71e-05 | 239 | 52 | 6 | CID000104802 | |
| Disease | cD177 antigen measurement | 2.19e-08 | 18 | 50 | 4 | EFO_0021866 | |
| Disease | Mitral valve prolapse | 3.14e-05 | 36 | 50 | 3 | HP_0001634 | |
| Disease | FEV/FEC ratio | 3.38e-05 | 1228 | 50 | 10 | EFO_0004713 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 5.88e-05 | 7 | 50 | 2 | EFO_0801906 | |
| Disease | response to virus | 1.53e-04 | 11 | 50 | 2 | GO_0009615 | |
| Disease | Mitral valve prolapse, response to surgery | 1.84e-04 | 12 | 50 | 2 | EFO_0009951, HP_0001634 | |
| Disease | laryngeal squamous cell carcinoma | 3.77e-04 | 17 | 50 | 2 | EFO_0006352 | |
| Disease | chronic obstructive pulmonary disease | 1.04e-03 | 688 | 50 | 6 | EFO_0000341 | |
| Disease | arteriosclerosis (is_marker_for) | 1.11e-03 | 29 | 50 | 2 | DOID:2349 (is_marker_for) | |
| Disease | rhinitis (is_implicated_in) | 1.19e-03 | 30 | 50 | 2 | DOID:4483 (is_implicated_in) | |
| Disease | asthma (is_marker_for) | 1.29e-03 | 126 | 50 | 3 | DOID:2841 (is_marker_for) | |
| Disease | peak expiratory flow | 1.52e-03 | 498 | 50 | 5 | EFO_0009718 | |
| Disease | pulmonary function measurement, forced expiratory volume | 1.80e-03 | 37 | 50 | 2 | EFO_0003892, EFO_0004314 | |
| Disease | QT interval | 2.06e-03 | 534 | 50 | 5 | EFO_0004682 | |
| Disease | Chagas cardiomyopathy | 2.54e-03 | 44 | 50 | 2 | EFO_0005529 | |
| Disease | migraine disorder | 3.13e-03 | 357 | 50 | 4 | MONDO_0005277 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEQVPPCPIGMSQLW | 1476 | Q14031 | |
| VHPMELGPTATGQPW | 761 | Q9BZ11 | |
| TPGPVCQLMWSPMSH | 616 | Q96MT7 | |
| WGHCPPPTTQPMLER | 536 | Q96MI9 | |
| MCSPPPHSPEIIYSW | 216 | O94779 | |
| SSCMRSLQPPAPVWG | 6 | P50221 | |
| GHSDQCWMPPLPSPS | 926 | Q9HCL0 | |
| MVHPGSCALWVSQPP | 11 | O14931 | |
| THLPWGPMDLIVSNP | 226 | Q9Y5R4 | |
| SWMPVPPQAIKTSHL | 46 | Q63ZY6 | |
| ASSPMPCSPSGHWSP | 726 | Q13219 | |
| CHVTGSPPPTIMWLK | 1756 | Q96RW7 | |
| QSALMPPAPTTRWCS | 1066 | Q8TES7 | |
| SNSLLVCPMEGWIPP | 4131 | Q4G0P3 | |
| CLLPPSGSTSAHMPW | 431 | P24394 | |
| VHELPMGIPAPWGTS | 21 | O95838 | |
| MGIPAPWGTSPLSFH | 26 | O95838 | |
| LSGNTAHWSMKPPIC | 456 | Q2VPA4 | |
| NCSSTPWHLPPMHMT | 306 | O15033 | |
| MPTPRGCNSALVTWP | 156 | P32019 | |
| MGPLSAPPCTEHIKW | 1 | Q9UQ72 | |
| IEVMFSPHPCPTWTL | 386 | Q8NEC7 | |
| CPSTHPPIRVMQWNI | 136 | Q9UK39 | |
| HPSQEGLWALPSLPM | 6 | Q8IYJ3 | |
| SKSGWRPPSPEMLCH | 1856 | Q6YHU6 | |
| PSLEDISCNTWPSMP | 391 | Q99593 | |
| MGPLSAPPCTQHITW | 1 | Q00889 | |
| MPHSVTLRGPSPWGF | 1 | P50479 | |
| SVPWACKQGTPPMIS | 176 | Q9NYZ4 | |
| PMHNWPRPIPLSSST | 221 | B1ATL7 | |
| MGPLSAPPCTQHITW | 1 | Q13046 | |
| MNLTWIHTTPICNPP | 256 | Q8N365 | |
| QKWMPGSQHVPTCSP | 106 | O60543 | |
| CAQMLPPNLSPHAPW | 256 | O43734 | |
| MPWQSVPLEESLPTC | 456 | O95985 | |
| LMGPAQHTSWPCGSA | 16 | P52740 | |
| LDLPGSCTSFWPMSP | 231 | A6NNY8 | |
| PPPVVTWTHFGCPME | 1091 | Q15772 | |
| PGNILSTAPPWLRHM | 641 | Q9NXZ1 | |
| ASWPSCTPGHMPTLP | 281 | Q6NTF9 | |
| CLTPSMSEPPEGSWS | 356 | Q92785 | |
| LQPSQWGMLCPSDTP | 471 | Q9NW08 | |
| MLPNDPLPHICNWVS | 506 | Q96F45 | |
| SSAPKQGPLHPWMTL | 681 | Q86TV6 | |
| PVCHSSPWLSPLASM | 646 | Q8TEQ8 | |
| HMRGHSPSQLPPGWT | 446 | Q9Y2Y4 | |
| GCSSWVPGMETSLPP | 1881 | Q5VWN6 | |
| VSCTASGNPPPQIMW | 686 | P35968 | |
| MGPLSAPPCTEHIKW | 1 | P11465 | |
| MGPLSAPPCTQHITW | 1 | Q15238 | |
| WPPAQGLAMRTHCPT | 121 | Q96M66 | |
| GPQPSTMPLWCLLAA | 6 | Q6UXV3 | |
| VISPPCTGSSEHWKP | 1146 | Q14789 | |
| TTNTWTLLPHMPCPV | 846 | Q96CT2 | |
| PCTTMGNPKPSVSWI | 141 | O15146 |